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Marc Laskar
CHU Dupuytren, chirurgie cardiovasculaire, Limoges, France
Objective: The aim of the study was to have an exact evaluation of the
inflow and outflow of cardiac surgeons in France.
Methods: The French Society of Thoracic and Cardiovascular Surgery
(SFCTCV) has built a database of the surgeons involved in thoracic and/or car-
diac surgery in France. It includes all the surgeons who do performe cardiac or
thoracic surgery whatever the number of operations performed per year, being
or not member of the SFCTCV, and all the trainees as soon as they have
expressed the will of becoming involved in thoracic and/or cardiac surgery.
Results: The database includes 552 senior surgeons (Professors, staff phy-
sicians, private practitioners) practising cardiac and/or thoracic surgery. 208
practice cardiac, 273 thoracic and 71 both. The “inflow” includes 129 resi-
dents and 75 senior residents.
Global analysis of age distribution shows a mean predictable outflow of
17.3 senior surgeons a year between 2012 and 2021. The “nflow” of senior
residents for the next 5 years is 18 a year. The number of residents is 30 per
year of residency.
Cardiac surgeons “outflow” will be 7.7 a year and the inflow of finishing
senior residents 10 a year. Sex distribution gives evidence of an increasing
feminization. Women’s ratio is 5%, 23% and 31% among senior surgeons,
senior residents, and residents respectively.
Conclusion: France will not run out of cardiothoracic surgeons. The inflow
compensates for the outflow of surgeons liable to stop their activity in the next
ten years.
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Background: Acute aortic syndromes (AAS) represent a wide range of
life-threatening pathologies. We assessed the feasibility and early results of an
immediate, round-the-clock, protocolized management of patients with AAS.
Method: In January 2009, we set up the SOS-Aorta program regrouping
intensivists, cardio-vascular and endovascular surgeons available around the
clock. All patients admitted via SOS-aorta were included in a prospective
registry. We compared the early results of this registry to the one of a retrospec-
tive cohort of patients admitted for AAS before the creation of this program.
Result: From January 2006 to December 2011, a total of 451 patients were
admitted for AAS (174 before and 287 after SOS-Aorta). The average number
of patients treated annually was 58±6.6 in the 3-years before SOS-Aorta. It
increased significantly to 96±17 (p<0.05) after SOS-Aorta. The overall in-hos-
pital mortality in the early period was 36.4±1.84%. It decreased significantly
to 21.6% (p<0.01) after SOS-Aorta. The first 122 patients from the SOS-aorta
registry were reviewed: mean age 66 (56-78), 70% men. Chest or abdominal
pain were present in 68,8%. Typical migrating pain suggestive of aortic dis-
section was present in only 4%. Final diagnosis xas: acute Type A dissection
in 52%, type B in 19% and ruptured aneurysm in 25%. Patients were fre-
quently in critical condition: 25% with shock, 8,2% cardiac arrest, 11% acute
coronary syndrom and 8% tamponade. The mean SAPS2 score (New Simpli-
fied Acute Physiology Score) was 30 [24-37]. 79% of the patients underwent
emergent surgery in a mean time frame of 1,27 hours (0,24-7,63). Multivariate
analysis showed that SAPS2 score was the only significant predictor of mor-
tality OR:1,12 (IC95%:1,05-1,18), p<0,001.
Conclusion: Setting-up the SOS-Aorta program has increased significantly
the number of patients admitted for AAS. It resulted in a significant improve-
ment of in-hospital mortality for these patients with otherwise immediate
severe prognosis.
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Introduction: The choice of aortic valve substitute in young women
should take the desire for pregnancy into account. Currently however, little is
known about pregnancy-related outcomes following aortic valve replacement
(AVR). The aim of this study was to assess cardiac, maternal and fetal-related
outcomes in female patients with AVR during and after pregnancy.
Method: A retrospective study of all AVRs performed in women under the
age of 40 years at our institution was undertaken. These patients were pro-
spectively followed at our dedicated valve clinic. Patients with Turner syn-
drome or having undergone a hysterectomy and/or tubal ligation were
excluded. Cardiovascular, maternal and fetal outcomes were gathered from
medical records and telephone interviews.
Results: From 1976 to 2011, 77 women underwent 86 isolated AVRs: 65
mechanical prostheses (MPs) and 21 bioprostheses (BPs). The follow-up was
81% complete. Ten patients (13%) had 19 pregnancies at a mean age of 28±6
years. Of those, 5 ended in miscarriages (26%; n=4 BPs and n=1 MPs).
Twelve (63%) pregnancies occurred in patients with BPs. The following
adverse events were reported: two hospitalizations for syncope (25%), func-
tional prosthetic valve deterioration during pregnancy necessitating reinterven-
tion 6 months post-partum (12%) and 4 miscarriages (33%). 
Nine of the 65 women (14%) with MPs had a hysterectomy or endometrial
ablation for excessive uterine bleeding, precluding childbearing potential. In
total, 7 pregnancies were reported in women with MPs. Two of them were ter-
minated (n=1, medical advice and n=1 embolic myocardial infarction). The
following peri-partum complications occurred: two embolic myocardial
infarctions (33%), a postpartum bleeding (16%) and an urgent caesarean for
placental abruption (16%). 
No fetal adverse events were observed.
Conclusion: Findings from this study suggest that pregnancy in women
with prosthetic AVR is associated with an increased risk of cardiac adverse
outcomes.
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